EcoDrugPlus

Dihydropyridine-Sensitive L-Type Skeletal Muscle Calcium Channel Subunit Alpha-1-Like

Ensembl ID : ENSSTUG00000044803
Gene Symbol: LOC115208150
3 Cross references
187 Possible Orthologues:

Dihydropyridine-Sensitive L-Type Skeletal Muscle Calcium Channel Subunit Alpha-1-Like

Ensembl ID : ENSSTUG00000043975
Gene Symbol: LOC115167827
3 Cross references
199 Possible Orthologues:

Dihydropyridine-Sensitive L-Type Skeletal Muscle Calcium Channel Subunit Alpha-1-Like

Ensembl ID : ENSSTUG00000033918
Gene Symbol: LOC115150281
3 Cross references
187 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSSTUG00000005749
Gene Symbol: DPYD
3 Cross references
166 Possible Orthologues:

Dihydropyrimidine Dehydrogenase [Nadp(+)]

Ensembl ID : ENSSTUG00000029381
Gene Symbol: LOC115156802
3 Cross references
203 Possible Orthologues:

Dipeptidyl Peptidase 1-Like

Ensembl ID : ENSSTUG00000018723
Gene Symbol: LOC115206587
3 Cross references
232 Possible Orthologues:

Dipeptidyl Peptidase 1-Like

Ensembl ID : ENSSTUG00000013066
Gene Symbol: LOC115206584
3 Cross references
232 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSSTUG00000047802
Gene Symbol: DDR2
3 Cross references
192 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSSTUG00000015773
Gene Symbol: DDR2
3 Cross references
198 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSSTUG00000013276
Gene Symbol: DDR2
3 Cross references
197 Possible Orthologues:

Disintegrin And Metalloproteinase Domain-Containing Protein 17-Like

Ensembl ID : ENSSTUG00000025308
Gene Symbol: LOC115162529
3 Cross references
201 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSSTUG00000046258
Gene Symbol: DRD1
3 Cross references
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).